Recent Trials of Atrial Fibrillation Therapy
European Journal of Arrhythmia & Electrophysiology · 2015
DOI: 10.17925/ejae.2015.01.01.17 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Arrhythmia & Electrophysiology, 2015. Verfasst von Baktash Morrad und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in clinical practice. It may cause significant symptoms and impair both functional status and quality of life. Without therapeutic intervention, affected patients are at increased risk of mortality and morbidity, so AF places a major burden on healthcare systems. Many trials have been published on AF therapy in recent years. In this editorial, we will briefly discuss recent trials of AF therapies.
Zitieren
APA
Morrad, B., & Gorenek, B. (2015). Recent Trials of Atrial Fibrillation Therapy. European Journal of Arrhythmia & Electrophysiology. https://doi.org/10.17925/ejae.2015.01.01.17
Vancouver
Morrad B, Gorenek B. Recent Trials of Atrial Fibrillation Therapy. European Journal of Arrhythmia & Electrophysiology. 2015. doi:10.17925/ejae.2015.01.01.17
BibTeX
@article{Morrad2015,
author = {Morrad, Baktash and Gorenek, Bulent},
title = {Recent Trials of Atrial Fibrillation Therapy},
journal = {European Journal of Arrhythmia & Electrophysiology},
year = {2015},
doi = {10.17925/ejae.2015.01.01.17}
}
EUVIMED